Monsanto
Nestle Purina Petcare
Sigma-Aldrich
University of Nebraska
Our device and diagnostic clients vary in size based on revenues and business scope. We routinely advise these companies on device classification matters, filing for market clearance or approval, complying with both general and specific controls and market place liability issues, including products liability. Our representation extends to the new emerging market of mobile medical applications and the FDA’s regulation of these emerging device/diagnostics. We are advising clients on the new “GUDID” program the FDA has launched for medical devices, as well as on compliance with the medical device good manufacturing practice regulations.
Our counseling in this field includes:
We also advise a select group of our clients on the reprocessing of medical devices and the requirements related to the reprocessing and subsequent remarketing of reprocessed devices.
EEOC issues new guidance on COVID-19 vaccinations in the workplace
Litigation fees may be tax-deductible, confirms new Tax Court ruling
Participate in standard-setting bodies? The enforceability of your patents could be affected
Supreme Court overturns the Federal Circuit, granting more flexibility to biosimilar makers
What to do when the government comes calling: A checklist for handling facility inspections
USPTO launches new proof of use audit program
The shifting standard for IPR estoppel: Where are we now?
5 tips for environmental due diligence in business transactions
D.C. appellate court strikes another nail in the coffin for the Frye test
What U.S. companies need to know about their IP rights post-Brexit
New OSHA reporting and anti-retaliation rules
USPTO publishes new (and largely improved) guidance for subject matter eligibility
Federal Circuit rules objective prong of willful infringement best decided by judge
Clearview AI class-action may further test CCPA’s private right of action
‘Aggrieved Persons’ can bring suit under Biometric Information Privacy Act
DOJ continues to investigate, seek recoveries over compounding pharmacy fraud
Fate of legalized cannabis hinges on key vote
FDA to step up enforcement of homeopathic medicine
Recreational marijuana shake-up: Sessions revokes Cole Memorandum
Clinical trials Part I: The upcoming clinical trials reporting rule
The FDA's new Digital Health Plan
FDA’s Health Software PreCert Program to fast-track innovation
FSVP compliance dates arrive, challenges to food industry increase
ACI Drug and Medical Device Litigation Conference
Suzanne Galvin Quoted in Bloomberg Law Regarding Revised PFAS Settlement
World Trademark Review names Tom Polcyn to WTR 1000 list
Thompson Coburn releases 2021 Ag Innovation Survey on the impact of COVID, future of the ag industry
Jennifer Post talks to Business Insider about startup considerations before going public
Thompson Coburn supports agricultural growth through the Center for Soybean Innovation
Gain Executive Insights on trade developments with Thompson Coburn, Hispanic Chamber of Commerce
New Jersey jury awards $11 million to Thompson Coburn client in pet invention dispute
Agribusiness professionals enjoy hands-on farm simulation at Thompson Coburn
Thompson Coburn leads Missouri Soybean Merchandising Council to $600,000 jury verdict
Thompson Coburn earns corporate counsel recommendations five years running in national report
UMSL Research & Innovation Week to feature Tom Schlafly presentation
Steve Ritchey publishes article on patent basics for American Ceramic Society
Jeff Masson named ‘Influential Appellate Advocate’ for Monsanto Supreme Court win
Three partners named 2013 Up & Coming attorneys
Monsanto wins unanimous ruling from U.S. Supreme Court
19 Thompson Coburn partners named 2013 St. Louis Lawyers of the Year
Senior Counsel
|
St. Louis
|
Gordon is a highly experienced trial attorney who has achieved significant courtroom wins for clients in cases involving commercial disputes, white collar criminal defens... Gordon is a highly experienced trial attorney who has achieved significant ... |
|
|||||
Partner
|
St. Louis
|
Matt represents major agricultural companies in business-critical disputes. Matt represents major agricultural companies in business-critical disputes.... |
|
|||||
Partner
|
St. Louis
|
Companies navigating the complex regulatory landscape of the food and beverage industry turn to Kim Bousquet for her experience handling disputes and providing guidance. Companies navigating the complex regulatory landscape of the food and bever... |
|
|||||
Partner
|
St. Louis
|
Matt is vice chair of the Intellectual Property Practice Group. Matt is vice chair of the Intellectual Property Practice Group. |
|
|||||
Partner
|
St. Louis
|
Dan Cox is a litigator handling sophisticated business, tort, product liability, intellectual property, and class action defense cases. Dan Cox is a litigator handling sophisticated business, tort, product liabi... |
|
|||||
Senior Counsel
|
St. Louis
|
Chip's practice focuses on the representation of individuals, universities, and national and international companies in commercial transactions and counseling involving t... Chip's practice focuses on the representation of individuals, universities,... |
|
|||||
Partner
|
St. Louis
|
John represents domestic and international clients in complex litigation and multi-district litigation in some of the most challenging state and federal venues in the cou... John represents domestic and international clients in complex litigation an... |
|
|||||
Partner
|
St. Louis
|
Clients turn to Suzanne Galvin for results in complex high-profile litigation, particularly in the areas of pharmaceutical, medical device, and environmental exposure cla... Clients turn to Suzanne Galvin for results in complex high-profile litigati... |
|
|||||
Partner
|
St. Louis
|
Wil has a PhD in cellular and molecular biology and experience as research scientist working for a major biotechnology company. Wil has a PhD in cellular and molecular biology and experience as research ... |
|
|||||
Senior Counsel
|
Washington, D.C.
|
Benjamin is a corporate advisor and business strategist for a wide variety of privately-held businesses, manufacturers, financial institutions, and nonprofits. Benjamin is a corporate advisor and business strategist for a wide variety ... |
|
|||||
Partner
|
St. Louis
|
David strategically advises clients in a variety of intellectual property disputes including patent prosecution, IP litigation, brand protection, counterfeiting, Post-Gra... David strategically advises clients in a variety of intellectual property d... |
|
|||||
Partner
|
New York
|
James serves as legal adviser to investors, entrepreneurs, investment advisers and investment bankers as they fund or invest in new companies, grow established private co... James serves as legal adviser to investors, entrepreneurs, investment advis... |
|
|||||
Partner
|
St. Louis
|
Tom is Co-Chair of Thompson Coburn LLP's Corporate Department. Tom is Co-Chair of Thompson Coburn LLP's Corporate Department. |
|
|||||
Partner
|
St. Louis
|
Jeff is a litigator, former crop consultant, and agronomic crop specialist. Jeff is a litigator, former crop consultant, and agronomic crop specialist.... |
|
|||||
Partner
|
St. Louis
|
Chris is a valued strategic partner to emerging companies and the institutions and individuals that invest in them. Chris is a valued strategic partner to emerging companies and the instituti... |
|
|||||
Partner
|
St. Louis
|
Steve advises clients on domestic and international patent applications and provides comprehensive counsel on licensing and technology transfer. Steve advises clients on domestic and international patent applications and... |
|
|||||
Partner
|
St. Louis
|
Ben brings a background in electrical and computer engineering to his legal practice, which primarily focuses on the preparation and prosecution of patent applications. Ben brings a background in electrical and computer engineering to his legal... |
|
NOTICE.
Although we would like to hear from you, we cannot represent you until we know that
doing so will not create a conflict of interest. Also, we cannot treat unsolicited
information as confidential. Accordingly, please do not send us any information
about any matter that may involve you until you receive a written statement from
us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.